Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in the Critically Ill
NCT04010630Completed
- Sponsor
- CHU Montpellier
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium bicarbonate ringer's solution in metabolic acidosis and acute kidney injury (AKI) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Day 90 all-cause mortality. Started Oct 2019; status: completed.
02
Drugs
sodium bicarbonate ringer's solution
03
Conditions
metabolic acidosisacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04010630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04010630.